Krishna Institute of Medical Sciences Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹998Cr
- +29.3% YoY
- +3.9% QoQ
- Net profit
- ₹52Cr
- −43.5% YoY
- −27.8% QoQ
- Margin
- 20%
- −4 pp YoY
- −1 pp QoQ
Guidance rank: #11 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Management expects to double the top line within 3 years, and currently is performing better than that target (Page 19). Management expects no incremental debt going forward; debt to reduce quarter-on-quarter (Pg.19).
From Krishna Institute of Medical Sciences Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Management expects to double the top line within 3 years, and currently is performing better than that target (Page 19).
- Growth is anticipated from expanding specialties at existing hospitals without additional capex, contributing incremental revenue (Page 19).
- New hospitals like Thane and Bangalore clusters (Mahadevapura, Electronic City) are ramping up, with break-even expected by early to mid FY '27, supporting revenue growth (Pages 12-13).
- Telangana market is mature; expected occupancy growth to around 75-80% over 3-4 years with addition of beds boosting volume growth (Page 11).
- Tier 2 markets like Nashik had slower ramp-up due to payer mix but are now EBITDA positive with improved corporate empanelments expected to drive growth (Page 14).
2 more points from Krishna Institute of Medical Sciences Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Krishna Institute of Medical Sciences Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- For FY '27, an incremental capex of INR 500-600 crores is planned, primarily related to completing the full closure and setup of new facilities (Page 17).
- No concrete capex plans for FY '28 yet, as no new hospitals are currently scheduled for commissioning (Page 17).
- Post current major expansions, further expansions or new hospital additions may require exploring non-debt funding sources (Page 19).
- Expansion focus includes operationalizing and scaling existing new hospitals, especially large facilities like Kondapur (Page 16-17).
- Additional capacity additions in Bangalore planned on existing land already owned (Page 16).
2 more points from Krishna Institute of Medical Sciences Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Krishna Institute of Medical Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- There are mentions of ongoing expansion through adding new specialties at existing facilities without additional capex.
- Small acquisition opportunities have been considered but none considered sizable or significant at this time.
- Focus is primarily on scaling up and operationalizing existing hospitals like Thane, Bangalore (Mahadevapura and Electronic City), and Telangana cluster.
Krishna Institute of Medical Sciences Ltd — Quarterly revenue & net profit
Krishna Institute of Medical Sciences Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 998 | 772 | +29.3% | 961 | +3.9% |
| Operating profit (EBITDA) | 199 | 187 | +6.4% | 204 | -2.5% |
| Operating margin | 20% | 24% | -4 pp | 21% | -1 pp |
| Profit before tax | 69 | 135 | -48.9% | 97 | -28.9% |
| Net profit (PAT) | 52 | 92 | -43.5% | 72 | -27.8% |
| EPS (₹) | 1.33 | 2.22 | -40.1% | 1.67 | -20.4% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.3K Cr, net profit ₹75 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Krishna Institute of Medical Sciences's management said in earlier quarters
Others in Healthcare Services this season
- Vijaya Diagnostic Centre (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnostic Centre's Q3 FY26 earnings call —
- Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
- Chandan Healthca (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
- Rainbow Childrens Medicare (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Krishna Institute of Medical Sciences Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Krishna Institute of Medical Sciences Ltd Q3 FY26 results?
Management expects to double the top line within 3 years, and currently is performing better than that target (Page 19). Management expects no incremental debt going forward; debt to reduce quarter-on-quarter (Pg.19).
What is Krishna Institute of Medical Sciences Ltd share price analysis?
Krishna Institute of Medical Sciences Ltd currently shows a neutral. The stock trades at a P/E of 161.5 with a market cap of ₹33,691 Cr. Investors should review the full earnings analysis for detailed insights.
Is Krishna Institute of Medical Sciences Ltd planning capital expenditure?
For FY '27, an incremental capex of INR 500-600 crores is planned, primarily related to completing the full closure and setup of new facilities (Page 17).
Keep Krishna Institute of Medical Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
